Uniplan Investment Counsel’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-681,002
| Closed | -$4.27M | – | 140 |
|
|
2021
Q3 | $4.27M | Buy |
681,002
+1,737
| +0.3% | +$10.9K | 0.26% | 72 |
|
|
2021
Q2 | $6.7M | Buy |
679,265
+8,594
| +1% | +$84.7K | 0.39% | 48 |
|
|
2021
Q1 | $6.26M | Sell |
670,671
-412,453
| -38% | -$3.85M | 0.4% | 50 |
|
|
2020
Q4 | $5.2M | Buy |
1,083,124
+179,701
| +20% | +$862K | 0.36% | 56 |
|
|
2020
Q3 | $3.62M | Buy |
903,423
+136,757
| +18% | +$548K | 0.25% | 69 |
|
|
2020
Q2 | $3.52M | Sell |
766,666
-17,592
| -2% | -$80.7K | 0.25% | 67 |
|
|
2020
Q1 | $2.56M | Buy |
784,258
+109,154
| +16% | +$356K | 0.19% | 71 |
|
|
2019
Q4 | $2.91M | Buy |
675,104
+5,454
| +0.8% | +$23.5K | 0.17% | 93 |
|
|
2019
Q3 | $2.64M | Sell |
669,650
-35,580
| -5% | -$140K | 0.16% | 88 |
|
|
2019
Q2 | $3.28M | Buy |
+705,230
| New | +$3.28M | 0.21% | 82 |
|